12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant price movements. Prenetics Global, Chromocell Therapeutics, Nuwellis, MiNK Therapeutics, Accolade, and Tharimmune saw gains, while Trevena, Entero Therapeutics, NKGen Biotech, Kazia Therapeutics, Carmell, and Silexion Therapeutics experienced losses.
October 04, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Accolade shares rose 4.8% to $3.93, reflecting positive investor sentiment.
The 4.8% increase in Accolade's stock price suggests positive investor sentiment and potential favorable developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Chromocell Therapeutics shares rose 5.39% to $0.67, reflecting a positive market reaction.
The 5.39% rise in Chromocell's stock price indicates a favorable market response, possibly due to positive news or investor sentiment.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
MiNK Therapeutics stock moved up by 4.99% to $0.75, indicating positive market sentiment.
The 4.99% rise in MiNK Therapeutics' stock price reflects positive market sentiment, possibly due to favorable news or investor interest.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Nuwellis shares increased by 5.3% to $1.39, showing positive investor sentiment.
The 5.3% increase in Nuwellis' stock price suggests positive investor sentiment and potential favorable developments.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Prenetics Global's stock increased by 7.9% to $5.18, indicating positive investor sentiment.
The 7.9% increase in Prenetics Global's stock price suggests strong investor interest and potential positive developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Tharimmune shares rose 4.76% to $2.2, indicating positive market sentiment.
The 4.76% rise in Tharimmune's stock price reflects positive market sentiment, possibly due to favorable news or investor interest.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Carmell shares declined by 9.63% to $0.36, indicating negative market sentiment.
The 9.63% drop in Carmell's stock price suggests negative market sentiment, possibly due to adverse news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Entero Therapeutics shares declined by 16.63% to $0.5, reflecting negative market sentiment.
The 16.63% decline in Entero Therapeutics' stock price indicates negative market sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Kazia Therapeutics shares fell 10.12% to $0.4, reflecting negative market sentiment.
The 10.12% decline in Kazia Therapeutics' stock price indicates negative market sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
NKGen Biotech shares fell 14.25% to $0.34, indicating negative market sentiment.
The 14.25% drop in NKGen Biotech's stock price suggests negative market sentiment, possibly due to adverse news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Silexion Therapeutics stock fell 6.77% to $0.43, reflecting negative market sentiment.
The 6.77% decline in Silexion Therapeutics' stock price indicates negative market sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Trevena shares fell 42.5% to $2.65, indicating significant negative market sentiment.
The 42.5% drop in Trevena's stock price suggests significant negative sentiment, possibly due to adverse news or developments.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90